Concepedia

Xiaoyong Tang

XT

Statistics

Publications

7

Citations

168

H-Index

7

Active since

2012

Affiliations

Shandong First Medical University(Current)

Shandong Tumor Hospital

Jining First People's Hospital

Xiaoyong Tang is an author at Shandong First Medical University specializing in medicine, oncology, and second-line chemotherapy.

Publications per year

2012–2024

7

Publications

7

Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer

Xiaoyan Yin, Wanqi Zhu, Xiaoyong Tang et al. · BMC Cancer · 2024 · 38 citations · Full text

, , +17

Overexpressed FOXC2 in ovarian cancer enhances the epithelial-to-mesenchymal transition and invasion of ovarian cancer cells

Bo Liu, Shumei Han, Xiaoyong Tang et al. · Oncology Reports · 2014 · 35 citations · Full text

, , +16

S-1 plus CIK as second-line treatment for advanced pancreatic cancer

Meng Wang, Shi Sheng-bin, Jie-Lin Qi et al. · Medical Oncology · 2013 · 32 citations

, , +8

CIZ1 regulates the proliferation, cycle distribution and colony formation of RKO human colorectal cancer cells

Jing Yin, Chang-Liang Wang, Xiaoyong Tang et al. · Molecular Medicine Reports · 2013 · 20 citations · Full text

, , +17

Phase II trial of capecitabine combined with thalidomide in second-line treatment of advanced pancreatic cancer

Shengbin Shi, Meng Wang, Xiaoyong Tang et al. · Pancreatology · 2012 · 15 citations

, , +11

1–5 of 7